- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.95 | 1.93 |
NAV | ₹412.09 | ₹37.42 |
Fund Started | 04 Jun 1999 | 25 Jun 2018 |
Fund Size | ₹3416.13 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 0.50% if redeemed within 15 days | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.95
1.93
NAV
₹412.09
₹37.42
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹3416.13 Cr
₹5024.00 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 43.19% | 47.43% |
3 Year | 22.90% | 23.16% |
5 Year | 28.60% | 30.01% |
1 Year
43.19%
47.43%
3 Year
22.90%
23.16%
5 Year
28.60%
30.01%
Holding Analysis
Equity | 96.73% | 97.87% |
Cash | 3.27% | 2.13% |
Equity
96.73%
97.87%
Cash
3.27%
2.13%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.99% |
Max Healthcare Institute Ltd. | 6.26% |
Divi's Laboratories Ltd. | 6.21% |
Poly Medicure Ltd. | 5.38% |
Lupin Ltd. | 5.12% |
Lonza Group Ag | 4.55% |
Cipla Ltd. | 4.54% |
Krishna Institute of Medical Sciences Ltd | 3.99% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.51% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.35% |
Dr. Reddy's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 8.07% |
Lupin Ltd. | 4.59% |
Aurobindo Pharma Ltd. | 4.57% |
Gland Pharma Ltd. | 4.22% |
Apollo Hospitals Enterprise Ltd. | 3.80% |
Zydus Lifesciences Ltd. | 2.93% |
Divi's Laboratories Ltd. | 2.69% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Tanmaya Desai | Dharmesh Kakkad |
Start Date | 27 Jun 2011 | 23 Feb 2021 |
Name
Tanmaya Desai
Dharmesh Kakkad
Start Date
27 Jun 2011
23 Feb 2021
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Jun 1999 | 25 Jun 2018 |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018
